{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:08:58Z","timestamp":1778519338313,"version":"3.51.4"},"reference-count":42,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Background: Accurate identification of complete or near-complete responders after total neoadjuvant therapy (TNT) is critical for selecting candidates for non-operative management in locally advanced rectal cancer (LARC). While static inflammatory biomarkers have been widely investigated, the predictive value of dynamic changes in systemic inflammation during TNT remains unclear. This study evaluated whether changes in the Pan-Immune Inflammation Value (PIV) correlate with magnetic resonance imaging tumor regression grade (mrTRG) and regrowth risk. Methods: Seventy-three patients with LARC treated with TNT between 2018 and 2024 were retrospectively analyzed. Patients were classified as complete\/near-complete responders (C-NCRG; mrTRG1\u20132) or residual disease group (RDG; mrTRG3\u20135). The PIV was calculated as (platelet \u00d7 monocyte \u00d7 neutrophil)\/lymphocyte at treatment initiation (first-PIV), three weeks after completion of chemotherapy (last-PIV), and at regrowth (Rg-PIV). Dynamic changes were defined as \u0394-PIV (last-PIV minus first-PIV) and \u0394Rg-PIV (Rg-PIV minus first-PIV). Receiver operating characteristic analysis identified optimal cutoffs, and logistic regression assessed independent associations. Results: The baseline PIV did not differ between groups. Last-PIV and \u0394-PIV were significantly lower in the C-NCRG compared with RDG (p = 0.006). A \u0394-PIV cutoff of \u221236.9 discriminated responders (AUC = 0.705; sensitivity 53.7%; specificity 84.4%) and remained independently associated with MRI response in multivariate analysis. In the non-operative management cohort, \u0394Rg-PIV was significantly lower in patients without regrowth (p = 0.001), with a cutoff of \u221277.72 (AUC = 0.794; sensitivity 88.9%; specificity 66.7%). Overall survival was superior in the C-NCRG (p = 0.01). Conclusions: A dynamic reduction in the PIV during TNT is significantly associated with favorable MRI response and lower regrowth risk in LARC. PIV dynamics may serve as a noninvasive complementary biomarker to support response assessment and stratification in organ-preservation strategies.<\/jats:p>","DOI":"10.3390\/curroncol33050278","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:39:32Z","timestamp":1778513972000},"page":"278","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Significant Correlation of Dynamic Pan-Immune Inflammation Value and Magnetic Resonance Imaging Response in Patients with Locally Advanced Rectal Cancer Treated with Total Neoadjuvant Therapy"],"prefix":"10.3390","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3010-6132","authenticated-orcid":false,"given":"Sukran","family":"Celikarslan","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1365-871X","authenticated-orcid":false,"given":"Duygu","family":"Karahacioglu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengi","family":"Gurses","sequence":"additional","affiliation":[{"name":"Department of Radiology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Selcukbiricik","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Balik","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya Salim","family":"Uymaz","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Rencuzogullari","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dursun","family":"Bugra","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahin","family":"Lacin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerim","family":"Kaban","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Vehbi Ko\u00e7 Foundation American Hospital, Istanbul 34365, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Perran Fulden","family":"Yumuk","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nil Molinas","family":"Mandel","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Armutlu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu","family":"Saka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Volkan","family":"Adsay","sequence":"additional","affiliation":[{"name":"Department of Pathology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Metin","family":"Vural","sequence":"additional","affiliation":[{"name":"Department of Radiology, VKF American Hospital, Istanbul 34365, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3837-1790","authenticated-orcid":false,"given":"Merve","family":"Duman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ba\u011fc\u0131lar Training and City Hospital, Istanbul 34200, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caglayan Selenge Beduk","family":"Esen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, VKF American Hospital, Istanbul 34365, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nulifer","family":"Kilic Durankus","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duygu","family":"Sezen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saliha Ezgi","family":"Oymak","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, VKF American Hospital, Istanbul 34365, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"Atagun","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8087-3140","authenticated-orcid":false,"given":"Ugur","family":"Selek","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ko\u00e7 University, Istanbul 34450, T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1038\/s41598-024-83105-z","article-title":"Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO\/ARO\/AIO-04 randomized phase 3 trial","volume":"15","author":"Gaedcke","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): A randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.annonc.2024.06.019","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: Long-term results of the UNICANCER-PRODIGE 23 trial","volume":"35","author":"Conroy","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)","volume":"40","author":"Jin","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0000000000003471","article-title":"Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes","volume":"271","author":"Petrelli","year":"2020","journal-title":"Ann. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e2030097","DOI":"10.1001\/jamanetworkopen.2020.30097","article-title":"Total Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer: A Systematic Review and Meta-analysis","volume":"3","author":"Kasi","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy","volume":"40","author":"Patil","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"114291","DOI":"10.1016\/j.ejca.2024.114291","article-title":"Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO\/ARO\/AIO-12 and the OPRA randomized phase 2 trials","volume":"210","author":"Fokas","year":"2024","journal-title":"Eur. J. Cancer"},{"key":"ref_9","unstructured":"NCCN (2025). Rectal Cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae), NCCN. Version 1."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1200\/JCO.2011.34.9068","article-title":"Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience","volume":"29","author":"Patel","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.radonc.2020.08.028","article-title":"Magnetic resonance imaging tumor response score (mrTRS) predicts therapeutic effect and prognosis of locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A prospective, multi-center study","volume":"151","author":"Guan","year":"2020","journal-title":"Radiother. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00384-024-04801-w","article-title":"Predictive value of rectal MRI variables for pathological complete response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy","volume":"40","author":"Li","year":"2025","journal-title":"Int. J. Color. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Yang, X.C., Liu, H., Liu, D.C., Tong, C., Liang, X.W., and Chen, R.H. (2022). Prognostic value of pan-immune-inflammation value in colorectal cancer patients: A systematic review and meta-analysis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1036890"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.17305\/bb.2024.10658","article-title":"Predictive and prognostic value of preoperative pan-immune-inflammation value in patients with locally advanced rectal cancer","volume":"25","author":"Shen","year":"2024","journal-title":"Biomol. Biomed."},{"key":"ref_15","first-page":"100579","article-title":"Predictive and prognostic value of inflammatory markers in locally advanced rectal cancer (PILLAR)\u2014A multicentric analysis by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Gastrointestinal Study Group","volume":"39","author":"Chiloiro","year":"2023","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_16","first-page":"406","article-title":"Artificial intelligence and radiomics in magnetic resonance imaging of rectal cancer: A review","volume":"4","author":"Ascione","year":"2023","journal-title":"Explor. Target. Antitumor Ther."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"van Rees, J.M., Wullaert, L., Gruter, A.A.J., Derraze, Y., Tanis, P.J., Verheul, H.M.W., Martens, J.W.M., Wilting, S.M., Vink, G., and van Vugt, J.L.A. (2023). Circulating tumour DNA as biomarker for rectal cancer: A systematic review and meta-analyses. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1083285"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.2214\/AJR.11.8210","article-title":"MRI after treatment of locally advanced rectal cancer: How to report tumor response\u2014The MERCURY experience","volume":"199","author":"Patel","year":"2012","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100223","DOI":"10.1016\/j.ejro.2020.100223","article-title":"Diffusion weighted imaging improves diagnostic ability of MRI for determining complete response to neoadjuvant therapy in locally advanced rectal cancer","volume":"7","author":"Chandramohan","year":"2020","journal-title":"Eur. J. Radiol. Open"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1245\/s10434-015-4687-9","article-title":"Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment","volume":"22","author":"Maas","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1245\/s10434-017-6213-8","article-title":"Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?","volume":"25","author":"Hupkens","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"103742","DOI":"10.1016\/j.clon.2024.103742","article-title":"Tumour-infiltrating Lymphocytes and Radiation Therapy in Rectal Cancer: Systematic Review and Meta-analysis","volume":"39","author":"Klein","year":"2025","journal-title":"Clin. Oncol. R. Coll. Radiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa051424","article-title":"Effector memory T cells, early metastasis, and survival in colorectal cancer","volume":"353","author":"Pages","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1172\/JCI122085","article-title":"Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing","volume":"129","author":"Bui","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13045-021-01187-y","article-title":"Neutrophils in cancer carcinogenesis and metastasis","volume":"14","author":"Xiong","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chen, X., Li, Y., Xia, H., and Chen, Y.H. (2023). Monocytes in Tumorigenesis and Tumor Immunotherapy. Cells, 12.","DOI":"10.3390\/cells12131673"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.ejca.2011.02.015","article-title":"Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling Danes","volume":"47","author":"Sajadieh","year":"2011","journal-title":"Eur. J. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wang, L., Wang, X., Guo, E., Mao, X., and Miao, S. (2022). Emerging roles of platelets in cancer biology and their potential as therapeutic targets. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.939089"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/02841869509093641","article-title":"Significance of increased neutrophils in patients with advanced colorectal cancer","volume":"34","author":"Satomi","year":"1995","journal-title":"Acta Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lee, S.J., Kim, K., and Park, H.J. (2022). Meta-Analysis on the Neutrophil-Lymphocyte Ratio in Rectal Cancer Treated With Preoperative Chemoradiotherapy: Prognostic Value of Pre- and Post-Chemoradiotherapy Neutrophil-Lymphocyte Ratio. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.778607"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00423-023-02786-8","article-title":"Prognostic role of platelet-to-lymphocyte ratio, neutrophil-to-lymphocyte, and lymphocyte-to-monocyte ratio in operated rectal cancer patients: Systematic review and meta-analysis","volume":"408","author":"Portale","year":"2023","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/14737140.2023.2194635","article-title":"Neutrophil-to-lymphocyte ratio predicts survival of patients with rectal cancer receiving neo-adjuvant chemoradiation followed by radical resection: A meta-analysis","volume":"23","author":"Colloca","year":"2023","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"10732748251334454","DOI":"10.1177\/10732748251334454","article-title":"Pretreatment MRI Parameters and Neutrophil-to-Lymphocyte Ratio Could Predict the Long-Term Prognosis of Locally Advanced Rectal Cancer Patients With Pathological Complete Response after Neoadjuvant Chemoradiotherapy","volume":"32","author":"Cui","year":"2025","journal-title":"Cancer Control"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101556","DOI":"10.1016\/j.suronc.2021.101556","article-title":"Prognostic and predictive value of neutrophil-to-lymphocyte ratio after curative rectal cancer resection: A systematic review and meta-analysis","volume":"37","author":"Hamid","year":"2021","journal-title":"Surg. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Ma, L., Yang, F., Guo, W., Tang, S., and Ling, Y. (2024). Prognostic role of platelet-to-lymphocyte ratio in patients with rectal cancer undergoing resection: A systematic review and meta-analysis. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1415443"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Wang, Y., Chen, L., Zhang, B., Song, W., Zhou, G., Xie, L., and Yu, D. (2021). Pretreatment Inflammatory-Nutritional Biomarkers Predict Responses to Neoadjuvant Chemoradiotherapy and Survival in Locally Advanced Rectal Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.639909"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3857\/roj.2023.00115","article-title":"Evaluation of the role of inflammatory blood markers in predicting the pathological response after neoadjuvant chemoradiation in patients with locally advanced rectal cancer","volume":"41","author":"Manoochehry","year":"2023","journal-title":"Radiat. Oncol. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"105548","DOI":"10.1016\/j.ebiom.2024.105548","article-title":"Circulating tumour DNA in predicting and monitoring survival of patients with locally advanced rectal cancer undergoing multimodal treatment: Long-term results from a prospective multicenter study","volume":"112","author":"Zhou","year":"2025","journal-title":"eBioMedicine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1158\/1078-0432.CCR-21-2404","article-title":"Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences","volume":"28","author":"Henriksen","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1093\/oncolo\/oyad336","article-title":"Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer","volume":"29","author":"Alden","year":"2024","journal-title":"Oncologist"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1200\/PO.20.00220","article-title":"Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer","volume":"5","author":"McDuff","year":"2021","journal-title":"JCO Precis. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"M\u00f6gele, T., H\u00f6ck, M., Sommer, F., Friedrich, L., Sommer, S., Schmutz, M., Altenburger, A., Messmann, H., Anthuber, M., and Kr\u00f6ncke, T. (2024). Circulating Tumor DNA for Prediction of Complete Pathological Response to Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer (NEORECT Trial). Cancers, 16.","DOI":"10.3390\/cancers16244173"}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/5\/278\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:17:43Z","timestamp":1778516263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/33\/5\/278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["curroncol33050278"],"URL":"https:\/\/doi.org\/10.3390\/curroncol33050278","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]}}}